Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 6,000 shares, an increase of 22.4% from the September 15th total of 4,900 shares. Based on an average daily volume of 600 shares, the short-interest ratio is presently 10.0 days.
Innate Pharma Stock Performance
Shares of Innate Pharma stock remained flat at $2.25 on Tuesday. Innate Pharma has a one year low of $1.93 and a one year high of $2.90. The firm’s 50-day moving average is $2.22 and its 200 day moving average is $2.29.
About Innate Pharma
Featured Stories
- Five stocks we like better than Innate Pharma
- What is the Euro STOXX 50 Index?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- How to Invest in the FAANG Stocks
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is a Special Dividend?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.